Fox Run Management L.L.C. Invests $931,000 in Select Medical Holdings Corporation $SEM

Fox Run Management L.L.C. purchased a new stake in shares of Select Medical Holdings Corporation (NYSE:SEMFree Report) during the second quarter, Holdings Channel.com reports. The fund purchased 61,339 shares of the health services provider’s stock, valued at approximately $931,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas bought a new stake in shares of Select Medical during the 1st quarter worth $269,000. Russell Investments Group Ltd. raised its position in Select Medical by 143.8% in the first quarter. Russell Investments Group Ltd. now owns 111,796 shares of the health services provider’s stock worth $1,867,000 after acquiring an additional 65,946 shares during the period. Empowered Funds LLC boosted its stake in Select Medical by 96.0% in the first quarter. Empowered Funds LLC now owns 613,801 shares of the health services provider’s stock valued at $10,250,000 after acquiring an additional 300,631 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Select Medical during the 2nd quarter valued at approximately $1,319,000. Finally, Vanguard Group Inc. increased its stake in shares of Select Medical by 4.7% during the 1st quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider’s stock worth $222,378,000 after purchasing an additional 603,079 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM opened at $13.30 on Monday. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $40.98. The stock’s 50-day simple moving average is $13.20 and its 200 day simple moving average is $14.08. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The stock has a market capitalization of $1.65 billion, a price-to-earnings ratio of 12.55, a price-to-earnings-growth ratio of 0.57 and a beta of 1.30.

Select Medical (NYSE:SEMGet Free Report) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.05. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the prior year, the business posted $0.43 earnings per share. The company’s revenue was up 7.2% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. Research analysts forecast that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th will be issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, November 12th. Select Medical’s dividend payout ratio (DPR) is presently 29.07%.

Analyst Upgrades and Downgrades

SEM has been the topic of several research analyst reports. UBS Group reiterated a “neutral” rating and issued a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, October 8th. Royal Bank Of Canada boosted their price objective on Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Finally, Benchmark reaffirmed a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $17.80.

Read Our Latest Stock Report on Select Medical

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.